Establishing school-centered asthma programs - 05/12/14
Abstract |
Asthma is a common chronic childhood disease associated with significant morbidity and high rates of school absenteeism, along with excessive costs for the patient and society. Asthma is a leading cause of school absenteeism, but this absenteeism is not equally distributed among those with asthma. Second to their home, school-aged children spend the largest portion of their wakeful hours at school. Opportunities exist to partner with schools to reach most children with asthma and those at the highest risk for asthma burden and in need of assistance. Asthma management at schools is important for pediatric pulmonologists and allergists, primary care providers, and the whole interdisciplinary team working alongside them to provide quality asthma care. The variability of asthma care services and programs provided in schools should prompt clinicians to understand their own school system and to advocate for appropriate services. Models of asthma care that place schools at the center or core of the model and coordinate evidence-based asthma care are applicable nationwide and might serve as a model for managing other chronic illnesses.
Le texte complet de cet article est disponible en PDF.Key words : Asthma, childhood asthma, asthma prevalence, asthma statistics, schools, school-centered asthma programs
Abbreviation used : ED
Plan
Series editors: Donald Y. M. Leung, MD, PhD, and Dennis K. Ledford, MD |
|
S.J.S. was supported by the Colorado Department of Public Health and Environment (14 FLA 62707), the Caring for Colorado Foundation, the McCormick Foundation, and GlaxoSmithKline (FLV 116794). Supported by the National Heart, Lung, and Blood Institute AsthmaNet grant U10 HL098075 and supported in part by Colorado CTSA grant UL1 RR025780 from National Center for Research Resources/National Institutes of Health (NIH) and UL1 TR000154 from NIH/National Center for Advancing Translational Sciences (NCATS). L.C. is supported by Colorado Department of Public Health and Environment (14 FLA 62707), Colorado CTSA grant UL1 TR001082 from NIH/NCRR and the Jessie Ball duPont Fund. M.G. is supported by the Colorado Department of Public Health and Environment (15 FLA 65726), the Caring for Colorado Foundation, the McCormick Foundation, and GlaxoSmithKline (FLV 116794). |
Vol 134 - N° 6
P. 1223-1230 - décembre 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?